Mentice AB (publ) (STO: MNTC)

Market Cap	646.89M
Revenue (ttm)	280.53M
Net Income (ttm)	-10.20M
Shares Out	25.57M
EPS (ttm)	-0.39
PE Ratio	n/a
Forward PE	62.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,905
Open	25.90
Previous Close	25.90
Day's Range	24.70 - 26.00
52-Week Range	24.70 - 71.40
Beta	1.11
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About Mentice AB

Mentice AB (publ) provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. The company operates through three segments: Systems, Software Licenses and Service. It offers software modules in the areas of acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, aortic valve implantation, endovascular aortic repair, below-the-knee intervention, carotid intervention, patient-specific simulation, coronary advanced, essential, and int...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 122
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MNTC

Financial Performance

In 2023, NAXS AB's revenue was 13.84 million, a decrease of -92.88% compared to the previous year's 194.32 million. Earnings were 4.35 million, a decrease of -97.58%.